| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |